Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Dongfeng Pharmaceutical is a comprehensive pharmaceutical enterprise based in Shijiazhuang, China, focusing on the production of active pharmaceutical ingredients (APIs) and finished drug products. The company is a significant manufacturer of xanthine derivatives, including caffeine, theophylline, and aminophylline, supplying these to global markets. Its product portfolio also encompasses a variety of therapeutic areas such as anti-infectives, cardiovascular health, and respiratory medicine. Hebei Dongfeng operates state-of-the-art, GMP-compliant facilities and provides contract manufacturing services to international partners. The company is recognized for its commitment to quality standards, holding various international certifications for its manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Dongfeng.